Malignant disease, blood diseases, collagen diseases, Turner syndrome, ovarian tumors, and other diseases where ovarian reserve is expected to decline due to the underlying disease or treatment.
Conditions
Interventions
None listed
Sponsors
St. Marianna University School of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients undergoing treatment that reduces fertility due to malignant diseases, blood disorders, collagen diseases, etc. In addition, patients who may have reduced fertility due to their constitution or disease, such as Turner syndrome.
Exclusion criteria
Exclusion criteria: If the attending physician deems it inappropriate If oocyte cryopreservation is judged to be dangerous due to poor physical condition, blood, or general condition. When the prognosis is extremely poor If the person and his or her family do not agree
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the number of oocytes retrieved, the number of mature oocytes, the number of pregnancies, and the patient's long-term ovarian reserve. The presence of ovarian hyperstimulation syndrome, infection and abnormal bleeding, and changes in mental status will also be evaluated. | — |
Secondary
| Measure | Time frame |
|---|---|
| Short-term and long-term ovarian reserve (AMH, FSH, E2, menstruation, etc.) | — |
Countries
Japan
Contacts
Public ContactSeido Takae
St. Marianna University School of Medicine Department of Obstetrics and Gynecology
Outcome results
None listed